This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Ghent. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Susann Eva Teneberg: Innovator in Glycosphingolipid Research
Introduction
Susann Eva Teneberg is a notable inventor based in Hindas, Sweden. She has made significant contributions to the field of glycosphingolipid research, particularly in relation to blood group determinants and their applications in veterinary medicine.
Latest Patents
Teneberg holds a patent related to the blood group A/B/H determinant on Type 1 Core glycosphingolipid chains. This invention serves as a recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic bacteria. The patent outlines the use of compounds comprising such determinants for the treatment of F18 infections in pigs and in screening methods.
Career Highlights
Susann Eva Teneberg is affiliated with the University of Ghent, where she continues her research and innovation in the field. Her work has implications for improving animal health and understanding bacterial infections.
Collaborations
Teneberg has collaborated with notable colleagues, including Annelies Coddens and Eric Cox, to advance her research and patent applications.
Conclusion
Susann Eva Teneberg's contributions to glycosphingolipid research and her innovative patent highlight her role as a significant figure in the scientific community. Her work not only enhances our understanding of bacterial interactions but also offers potential solutions for veterinary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
